| The Participating Institute | Download the Agenda |
The Rational
The Asian Pacific Organization for Cancer Prevention (APOCP) and the Asian National Cancer Center Alliance (ANCCA) have joined forces to address the difficulty and issues related to the care of cancer patients during the hard time of the pandemic.
COVID-19 pandemic has affected healthcare services across the globe and cancer care delivery is not an exception. Global lockdown has largely changed the cancer care practice from hospital visits to teleconsultations to check the spread of novel coronavirus 2019 as cancer patients are more susceptible to any infection than other individuals because of their systemic immunosuppressive state caused by the malignancy and anticancer treatments.
There have been many important issues to be addressed as far as cancer care delivery in amid COVID-19 pandemic is concerned. As this disease is very new, there is a paucity of data on experience of cancer management in this crisis from different countries and there is a need to address “The cancer care during the pandemic” in an area that direct and onsite communication is a subtle achievement.
The Asian Pacific Organization for Cancer Prevention (APOCP) and the Asian National Cancer Center Alliance (ANCCA) have joined forces to address the difficulty and issues related to the care of cancer patients during the hard time of the pandemic.
This join effort will be arranged as a half day scientific event consisting of delegate from major cancer center across Asia and Pacific Region. The forum aim is to bring a medium of sharing experience, learning from each other and finding the strategies to improve the care of caner patients while addressing and observing the pandemics difficulties. The meeting is open (Up to 500 people can attend), and in the ZOOM platform. To participate click in this button and register
| Click to Participate |
Participating Institutes and their delegates
| Malaysia | Singapore | C/CAN, Myanmar | Japan | Indonesia |
| National Cancer Institute Malaysia | National Cancer Centre Singapore | City cancer Challenge | National Cancer Center Japan | ِDharmais Hospital – National Cancer Center |
Head of Department Radiotherapy and Oncology / Senior Consultant Clinical Oncologist |
Medical Director, Singapore National Cancer Center |
C/Can Asia Representative |
Division Chief of International Collaborative Research, Center for Public Health Science, NCC Japan |
Director of Medical, Nursing, and Ancillary Services |
Dr Lau Fen Nee,
Dr. William Hwang
Dr. Aung Naing Soe
Dr Tomohiro Matsuda
Dr. Dr. Nina Kemala Sari| Bangladesh | Bhutan | Brunei | Iran | Nepal |
| National Institute of Cancer Research and Hospital, Dhaka, | JDWNR Hospital Thimphu Universityof Medical Science | Brunei Cancer Centre | Cancer Institute Iran | Kathmandu Cancer Centre, |
Director, National Institute of Cancer Research and Hospital, Dhaka, Bangladesh |
Head, Dept Of Oncology JDWNR Hospital Thimphu Professor Surgery KGUMS Thimphu Bhutan |
Head of the Brunei Cancer Centre |
Hematology-Oncology Research Center and Stem Cell Transplantation, Tehran University of Medical Sciences |
Kathmandu Cancer Centre, Nepal |
Pr Quazi Mushtaq Hussain
Dr Tashi Dendup Wangdi,
Dato Dr Babu Sukumaran,
Dr. Tavakoli
Kishore K.Pradhananga,| Pakistan | Vietnam | Taiwan | India | Myanmar | |
| Shokat Khanom Cancer Center | National Cancer Institute, National Cancer Hospital, | National Taiwan University Hospital | Lady Hardinge Medical College & Associated Hospitals | Yangon General Hospital | |
Shokat Khanom Cancer Center, Karachi, Pakistan |
Head of Department of Cancer Epidemiology, National Cancer Institute, National Cancer Hospital, Vietnam |
Ching-Hung Lin Attending Physician, Oncology Department, National Taiwan University Hospital |
Assistant Professor, Department of Radiation Oncology & Founder Secretary, Indian Society of Clinical Oncology |
Medical Oncology Department |
Dr. Aasim Yusuf,
Dr. GIANG Nguyen Huong
Dr Abhishek Shankar
Prof. Khin Thin MuThe Agenda of the Meeting
The times in the Agenda is based on Tehran Time
Find the time in your location
The meeting is open (up to 500 people can attend), and in the ZOOM platform. To participate click in this button and register
| Click to Participate |
| Time | Dur. (min) | Speaker | Topic | |
| 10:30 | 5 | 1.Dr. Alireza Mosavi Jarrahi, President of APOCP, Medical School, Shahid Behehsti University of Medical Sciences, Tehran Iran. 2. Dr. Tomohiro Matsuda, Welcome note from ANCCA | Welcome to the audience and country delegates | |
| 10:35 | 20 | Key Note speaker : Dr Partha Basu, International Agency for Research On Cancer (IARC), World Health Organization, Lyon, France | COVID-19 and Cancer Care : International and Regional impact | |
| 10:55 | 20 | Dr. Laureline Gatellier, Natinal Cancer Center, Japan Dr. Mela Dewi, National cancer center, Indonesia | 1.ANCCA presentation 2. Presentation of ANCCA manuscript based on survey in May-June) 3. Updated suggested way forward | |
| 11:15 | 15 (3 x 5’) | Low COVID incidence: Taiwan, Brunei, Bhutan | Country delegates | |
| 11:30 | 15 (3 x 5’) | Mid Low: Vietnam, Malaysia, Singapore | ||
| 11:15 | 15 (3 x 5’) | Mid high COVID: Myanmar, Japan, Nepal | ||
| 11:30 | 25 (5 x 5’) | High COVID: Pakistan, Bangladesh, Indonesia, Iran, India | ||
| 11:55 | 12 | C/CAN and City of Tomorrow | ||
| 12:07 | 43 | Discussions and new proposals | ||
| 12:50 | 10 | Dr William Hwang | Closing | |